Cogent Biosciences Inc (COGT)
6.00
-0.54
(-8.26%)
USD |
NASDAQ |
Apr 25, 16:00
6.00
0.00 (0.00%)
After-Hours: 20:00
Cogent Biosciences Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| September 30, 2020 | 23.16M |
| June 30, 2020 | 23.87M |
| March 31, 2020 | 26.48M |
| December 31, 2019 | 22.50M |
| September 30, 2019 | 11.02M |
| June 30, 2019 | 12.04M |
| Date | Value |
|---|---|
| March 31, 2019 | 10.57M |
| December 31, 2018 | 9.734M |
| September 30, 2018 | 8.052M |
| June 30, 2018 | 8.34M |
| March 31, 2018 | 8.753M |
| December 31, 2017 | 8.36M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
11.02M
Minimum
Sep 2019
26.48M
Maximum
Mar 2020
19.84M
Average
22.83M
Median
Revenue (TTM) Benchmarks
| QuidelOrtho Corp | 2.998B |
| NeuroOne Medical Technologies Corp | 2.816M |
| Agios Pharmaceuticals Inc | 26.82M |
| Tenon Medical Inc | 2.928M |
| DIH Holding US Inc | -- |